You may notice: Mild appetite suppression Increased fullness after meals Reduced cravings Smaller portion sizes Weight loss is typically minimal during this stage
3 Although several factors contributed to this rise in interest, two key developments have been particularly important: Celebrity endorsement: A number of high-profile celebrities, such as Elon Musk, have publicly credited GLP-1RA drugs with their transformative weight loss, leading to a spike in public interest in using the drugs for weight loss
Authors identified 51,408 adults with newly diagnosed type 2 diabetes and overweight or obesity who initiated treatment with either GLP-1 RAs (25,704 users) or SGLT2 inhibitors (25,704 users) following 1:1 propensity score matching to adjust for differences at baseline
"[Losing] five percent of your body weight every three months is considered clinically meaningful that's roughly a pound a week or less." Losing weight too quickly can worsen fatigue and accelerate muscle loss
, , ,
Yet, this result is lower compared to the 15.8% drop in body weight at semaglutide 2.4mg/weekly [51]